Get started
Author

Katie E. Lacy

Observed names: K E Lacy, K. E. Lacy, K. Lacy, K.E. Lacy, KATIE E. LACY, Kate Elizabeth Lacy, Katie E Lacy, Katie Elizabeth Lacy, Katie Lacy, Katie E   Lacy, Lacy, K, Lacy, K. E., Lacy, K.E., Lacy, Katie, Lacy, Katie E, Lacy, Katie E.
Observed institutions: University of London, Guy's Hospital, St Thomas' Hospital, King's College London, Guy's and St Thomas' NHS Foundation Trust, The Royal Free Hospital, Bristol Royal Infirmary, National Institute for Health and Care Research, South African Tuberculosis Vaccine Initiative, University College London
ORCID: 0000-0001-9694-9197
Observed ORCID: 0000-0001-9694-9197
OpenAlex ID: A5084589458
Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis
2011 · Ute Laggner, Paola Di Meglio, et al. · The Journal of Immunology · 320
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
2019 · Duaa O. Khair, Heather J. Bax, et al. · Frontiers in Immunology · 245
PDF
IgG4 subclass antibodies impair antitumor immunity in melanoma
2013 · Panagiotis Karagiannis, Amy E. Gilbert, et al. · Journal of Clinical Investigation · 239
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
2021 · Zena N. Willsmore, Ben G. T. Coumbe, et al. · European Journal of Immunology · 204
PDF
Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging
2009 · Elaine Agius, Katie E. Lacy, et al. · The Journal of Experimental Medicine · 189
PDF
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
2018 · Kristina M. Ilieva, Anthony Cheung, et al. · Frontiers in Immunology · 140
PDF
The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo
2008 · Milica Vukmanovic-Stejic, Elaine Agius, et al. · Journal of Clinical Investigation · 131
The Characterization of Varicella Zoster Virus–Specific T Cells in Skin and Blood during Aging
2015 · Milica Vukmanovic-Stejic, Daisy Sandhu, et al. · Journal of Investigative Dermatology · 117
PDF
BRAF inhibitors: resistance and the promise of combination treatments for melanoma
2017 · Merope Griffin, Daniele Scotto, et al. · Oncotarget · 112
PDF
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation
2017 · Milica Vukmanovic-Stejic, Emma S. Chambers, et al. · Journal of Allergy and Clinical Immunology · 104
PDF
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
2021 · Robert J. Harris, Anthony Cheung, et al. · Cancer Research · 100
Revisiting the role of B cells in skin immune surveillance
2015 · Isioma U. Egbuniwe, Sophia N. Karagiannis, et al. · Trends in Immunology · 89
PDF
Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
2011 · Amy E. Gilbert, Panagiotis Karagiannis, et al. · PLoS ONE · 89
PDF
Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma
2014 · Kristina M. Ilieva, Isabel Correa, et al. · Molecular Cancer Therapeutics · 88
PDF
Histological correlates of optical coherence tomography in non‐melanoma skin cancer
2012 · Andrew John Coleman, Thomas James Richardson, et al. · Skin Research and Technology · 81
Mantoux Test as a model for a secondary immune response in humans
2006 · Milica Vukmanovic-Stejic, John R. Reed, et al. · Immunology Letters · 81
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
2019 · Giulia Pellizzari, Coran Hoskin, et al. · EBioMedicine · 77
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
2016 · Louise Saul, Kristina M. Ilieva, et al. · Scientific Reports · 74
PDF
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma
2015 · Panagiotis Karagiannis, Federica Villanova, et al. · OncoImmunology · 73
PDF
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
2021 · Zena N. Willsmore, Robert J. Harris, et al. · Frontiers in Immunology · 71
PDF
B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
2017 · Giulia Chiaruttini, Silvia Mele, et al. · OncoImmunology · 71
PDF
Varicella Zoster–Specific CD4+Foxp3+ T Cells Accumulate after Cutaneous Antigen Challenge in Humans
2013 · Milica Vukmanovic-Stejic, Daisy Sandhu, et al. · The Journal of Immunology · 61
Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
2014 · SADEK MALAS, MICAELA HARRASSER, et al. · Oncology Reports · 50
PDF
Clinical and Translational Significance of Basophils in Patients with Cancer
2022 · Jitesh Chauhan, Chara Stavraka, et al. · Cells · 46
PDF
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
2023 · Jitesh Chauhan, Melanie Grandits, et al. · Nature Communications · 44
PDF
Works count: 137
Citation count: 3,511
H-index: 31
I10-index: 49
Year
Topic
Type